| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://iolcp.com | |
| Market Cap | 1,666.36 Cr. | |
| Enterprise Value(EV) | 1,692.87 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 17.74 | Trailing Twelve Months Ending 2022-12 |
| Price-Earning Ratio (PE) | 16.00 | Trailing Twelve Months Ending 2022-12 |
| Industry PE | 32.17 | Trailing Twelve Months Ending 2022-12 |
| Book Value / Share | 249.70 | Trailing Twelve Months Ending 2022-12 |
| Price to Book Value | 1.14 | Calculated using Price: 283.85 |
| Dividend Yield | 1.41 | Period Ending 2022-03 |
| No. of Shares Subscribed | 5.87 Cr. | 58,705,502 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| IOL Chemicals and Pharmaceuticals (IOLCP) is a leading organic chemicals manufacturers and suppliers. They are Indian manufacturer of industrial chemicals & bulk drugs for over two decades, by pursuing & implementing the highest standards of excellence in their operations, they have nurtured their capabilities by delivering consistent results and have earned the admiration of customers and stakeholders alike. | ||
| 1 Day |
|
+2.05% |
| 1 Week |
|
+1.21% |
| 1 Month |
|
-0.47% |
| 3 Month |
|
-25.67% |
| 6 Month |
|
-18.02% |
| 1 Year |
|
-23.14% |
| 2 Year |
|
-50.16% |
| 5 Year |
|
+257.04% |
| 10 Year |
|
+1042.25% |
| 1 years | 2022-03 | |
| Return on Equity (%) | 12.04 | |
| Return on Capital Employed (%) | 16.25 | |
| Return on Assets (%) | 8.28 |
| Particulars | 2 years | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 1,392 | 1,442 | |
| Non Curr. Liab. | 57 | 57 | |
| Curr. Liab. | 575 | 512 | |
| Minority Int. | |||
| Equity & Liab. | 2,024 | 2,011 | |
| Non Curr. Assets | 881 | 1,032 | |
| Curr. Assets | 1,143 | 979 | |
| Misc. Exp. not W/O | |||
| Total Assets | 2,024 | 2,011 |
| Particulars | 2 years | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
| Net Sales | 2,184 | 2,202 | |
| Other Income | 32 | 24 | |
| Total Income | 2,216 | 2,226 | |
| Total Expenditure | -1,926 | -2,027 | |
| PBIDT | 290 | 199 | |
| Interest | -8 | -14 | |
| Depreciation | -43 | -45 | |
| Taxation | -57 | -36 | |
| Exceptional Items | -14 | ||
| PAT | 168 | 104 | |
| Minority Interest | |||
| Share Associate | |||
| Other Related Items | |||
| Consolidated Net Profit | 168 | 104 | |
| Adjusted EPS | 29 | 18 |
| Particulars | 1 years | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 93 | |
| Cash Fr. Inv. | -120 | |
| Cash Fr. Finan. | -2 | |
| Net Change | -29 | |
| Cash & Cash Eqvt | 4 |
|
Wed, 29 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of lost share certificate |
|
Mon, 27 Mar 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mayadevi Polycot Ltd |
|
Fri, 10 Mar 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 46 Part A Para A of Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended read with corresponding circulars and notifications issued there under it is hereby informed that the management of the Company will be participating in Group Institutional Investors Virtual Meeting being organised by Systematix Group Mumbai on 10th March 2023. No unpublished price sensitive information (UPSI) will be shared during the aforesaid meetings. The above information will also be available on the website of the Company: www.iolcp.com. |
| Wed, 29 Mar 2023 |
Higher Delivery Quantity
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
Close Within 52 Week Low Zone
|
High Decrease in 3 Months
|
Equities
M.F.
Sectors